Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue Suppl 2
239 Engineering of potency-enhanced TCR-edited T cells for shared neoantigen-targeted cancer immunotherapy
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Cell Therapies
239 Engineering of potency-enhanced TCR-edited T cells for shared neoantigen-targeted cancer immunotherapy
Free
Online download statistics by month:
Online download statistics by month: November 2022 to October 2024
Abstract
Full
Pdf
Nov 2022
196
0
16
Dec 2022
74
0
3
Jan 2023
30
0
1
Feb 2023
30
0
6
Mar 2023
18
0
3
Apr 2023
40
0
1
May 2023
44
0
8
Jun 2023
38
0
3
Jul 2023
16
0
2
Aug 2023
12
0
2
Sep 2023
20
0
1
Oct 2023
28
0
2
Nov 2023
34
0
2
Dec 2023
26
0
2
Jan 2024
40
0
5
Feb 2024
32
0
2
Mar 2024
42
0
3
Apr 2024
28
0
1
May 2024
24
0
1
Jun 2024
24
0
1
Jul 2024
24
0
4
Aug 2024
12
0
5
Sep 2024
30
0
4
Oct 2024
18
0
8
Total
880
0
86
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?